Related references
Note: Only part of the references are listed.Modulating Self-Assembly of Amyloidogenic Proteins as a Therapeutic Approach for Neurodegenerative Diseases: Strategies and Mechanisms
Tingyu Liu et al.
CHEMMEDCHEM (2012)
A Novel Inhibitor of Amyloid β (Aβ) Peptide Aggregation FROM HIGH THROUGHPUT SCREENING TO EFFICACY IN AN ANIMAL MODEL OF ALZHEIMER DISEASE
Angela Fortner McKoy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Inhibition of Amyloid Formation
Torleif Hard et al.
JOURNAL OF MOLECULAR BIOLOGY (2012)
Human Serum Albumin as an Antioxidant in the Oxidation of (-)-Epigallocatechin Gallate: Participation of Reversible Covalent Binding for Interaction and Stabilization
Takeshi Ishii et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2011)
Toward the Discovery of Effective Polycyclic Inhibitors of α-Synuclein Amyloid Assembly
Gonzalo R. Lamberto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
The Flavanol (-)-Epigallocatechin 3-Gallate Inhibits Amyloid Formation by Islet Amyloid Polypeptide, Disaggregates Amyloid Fibrils, and Protects Cultured Cells against IAPP-Induced Toxicity
Fanling Meng et al.
BIOCHEMISTRY (2010)
The Sulfated Triphenyl Methane Derivative Acid Fuchsin Is a Potent Inhibitor of Amyloid Formation by Human Islet Amyloid Polypeptide and Protects against the Toxic Effects of Amyloid Formation
Fanling Meng et al.
JOURNAL OF MOLECULAR BIOLOGY (2010)
Pyrroloquinoline quinone inhibits the fibrillation of amyloid proteins
Jihoon Kim et al.
PRION (2010)
Impact of Tyr to Ala mutations on α-synuclein fibrillation and structural properties
Natasa Poklar Ulrih et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Dagmar E. Ehrnhoefer et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2008)
The fold of α-synuclein fibrils
Marcal Vilar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Investigation of α-synuclein fibril structure by site-directed spin labeling
Min Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Vitamin A potently destabilizes preformed α-synuclein fibrils in vitro:: Implications for Lewy body diseases
Kenjiro Ono et al.
NEUROBIOLOGY OF DISEASE (2007)
A century of Alzheimer's disease
Michel Goedert et al.
SCIENCE (2006)
Pyrroloquinoline quinone (PQQ) prevents fibril formation of α-synuclein
Masaki Kobayashi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
A century-old debate on protein aggregation and neurodegeneration enters the clinic
Peter T. Lansbury et al.
NATURE (2006)
Small molecule inhibitors of α-synuclein filament assembly
Masami Masuda et al.
BIOCHEMISTRY (2006)
Antioxidant compounds have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro
K Ono et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Molecular-level secondary structure, polymorphism, and dynamics of full-length α-synuclein fibrils studied by solid-state NMR
H Heise et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Alpha-Synuclein dysfunction in Lewy body diseases
GK Tofaris et al.
MOVEMENT DISORDERS (2005)
Dopamine and L-dopa disaggregate amyloid fibrils: implications for Parkinson's and Alzheimer's disease
J Li et al.
FASEB JOURNAL (2004)
The flavonoid baicalein inhibits fibrillation of α-synuclein and disaggregates existing fibrils
M Zhu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Rifampicin inhibits α-synuclein fibrillation and disaggregates fibrils
J Li et al.
CHEMISTRY & BIOLOGY (2004)
Vitamin A exhibits potent antiamyloidogenic and fibril-destabilizing effects in vitro
K Ono et al.
EXPERIMENTAL NEUROLOGY (2004)
Caught in the act:: α-synuclein is the culprit in Parkinson's disease
JL Eriksen et al.
NEURON (2003)
Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
KA Conway et al.
SCIENCE (2001)
Share Paper
